Eledon Pharmaceuticals, Inc.

Q3 2026 13F Holders

Symbol
ELDN
CUSIP
28617K101
Type
Equity
Class
COM
Num filings
7
Total reported value, excl. options
$54.7 k
Manager Report Date Value ($000) Shares Option Type